Personality, Addiction, Dopamine: Insights from Parkinson's Disease

被引:265
|
作者
Dagher, Alain [1 ]
Robbins, Trevor W. [2 ,3 ]
机构
[1] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[2] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England
[3] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
IMPULSE CONTROL DISORDERS; NUCLEUS-ACCUMBENS DOPAMINE; GOAL-DIRECTED BEHAVIOR; REWARD-RELATED STIMULI; BASAL GANGLIA; D-3; RECEPTOR; FRONTOTEMPORAL DEMENTIA; INCENTIVE SALIENCE; DRUG-ADDICTION; MESENCEPHALIC DOPAMINE;
D O I
10.1016/j.neuron.2009.01.031
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In rare instances, patients with Parkinson's disease (PD) may become addicted to their own medication or develop behavioral addictions such as pathological gambling. This is surprising because PD patients typically have a very low incidence of drug abuse and display a personality type that is the polar opposite of the addictive personality. These rare addictive syndromes, which appear to result from excessive dopaminergic medication use, illustrate the link between dopamine, personality, and addiction. We describe the clinical phenomena and attempt to relate them to current models of learning and addiction. We conclude that persistently elevated dopaminergic stimulation promotes the development and maintenance of addictive behaviors.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 50 条
  • [31] Addicted to dopamine - the dopamine dysregulation syndrome in Parkinson's disease
    Evans, A. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S196 - S196
  • [32] Prodromal Parkinson's disease - insights from UK Biobank
    Street, Duncan
    Whiteside, David
    Rittman, Timothy
    Rowe, James
    NEUROLOGY, 2021, 96 (15)
  • [33] Translating insights from optogenetics into therapies for Parkinson's disease
    Gittis, Aryn H.
    Yttri, Eric A.
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2018, 8 : 14 - 19
  • [34] Parkinson's Disease and Cancer Insights for Pathogenesis from Epidemiology
    D'Amelio, Marco
    Ragonese, Paolo
    Sconzo, Gabriella
    Aridon, Paolo
    Savettieri, Giovanni
    STEROID ENZYMES AND CANCER, 2009, 1155 : 324 - 334
  • [35] The role of dopamine in the brain - lessons learned from Parkinson's disease
    Meder, David
    Herz, Damian Marc
    Rowe, James Benedict
    Lehericy, Stephane
    Siebner, Hartwig Roman
    NEUROIMAGE, 2019, 190 : 79 - 93
  • [36] VIP protects from dopamine toxicity: relevance for Parkinson's disease
    Offen, D
    Melamed, E
    Fridkin, M
    Brenneman, DE
    Gozes, I
    BRAIN RESEARCH, 1999, 848 (1-2) : A36 - A36
  • [37] MISSED INSIGHTS FOR EARLIER MANAGEMENT OF PARKINSON'S DISEASE AND THE VALUE OF DOPAMINE TRANSPORTER (DAT) SCANS
    Hafeez, Mohib
    Pangle, Amanda
    Wei, Jeanne
    Azhar, Gohar
    INNOVATION IN AGING, 2023, 7 : 1081 - 1081
  • [38] Missed Insights for Earlier Management of Parkinson's Disease and the Value of Dopamine Transporter (DAT) Scans
    Hafeez, Mohib
    Eoff, Elizabeth
    Wei, Jeanne
    Azhar, Gohar
    GERIATRICS, 2024, 9 (05)
  • [39] Molecular Insights into Parkinson's Disease
    Rochet, Jean-Christophe
    Hay, Bruce A.
    Guo, Ming
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES, 2012, 107 : 125 - 188
  • [40] New insights into Parkinson's disease
    Chung, KKK
    Dawson, VL
    Dawson, TM
    JOURNAL OF NEUROLOGY, 2003, 250 (Suppl 3) : 15 - 24